Once a PI patient is released with symptoms, or without symptoms, and a prognosis of likely exacerbations with a future medical estimation of $1500 over then next 2 years, how am I supposed to release them from care when they still have ongoing needs?
We have discussed this with several different experts. The consensus is that the patient should not be released from the PI case until BOTH of the following have occurred:
the ortho/neuro exam is normal or has stabilized AND
outcome assessments show no significant measurable and functional change after 3 exams over varying times. This one, known as a trial withdrawal of care, is commonly overlooked by chiropractors
If the patient shows no measurable and functional change and they don't worsen without treatment, they should either be released from care or referred out. During the trial withdrawal of care, the patient should be instructed to gradually and carefully increase their activity level to what is was before the injury. It is essential to know if they will be fine without ongoing care. If their situation worsens after not seeing you for a week (or two or three), then you should continue treating, based on their exam findings and outcome assessments.
At some point, though, if they are still having issues, it becomes necessary to stop and say that we tried a withdrawal of care and explain to the PI payer that the patient is unable to go without treatment for more than x days/weeks/months. That becomes the supporting rationale to explain the need for ongoing care and at what cost. When persistent injury symptoms remain, it is an indication that an impairment rating is appropriate.
Documenting their condition as "static" might be a wise thing to do (if applicable, of course), so as to help validate that the patient has not officially returned to pre-injury status or MMI.
If you have questions or comments about this article please contact us. Comments that provide additional related information may be added here by our Editors.
To determine the dosage, size, doses per package and how many billing units are in each package, refer to the NDC number.
Take a look at the following
J1071 - Injection, testosterone cypionate, 1mg
For example; using NCD # 0009-0085-10 there are 10 doses of 100 mL
(100 mg/mL = 1 mL and there are ...
As we begin returning back to work, we will all face a new normal. The COVID-19 pandemic has changed the face of business. While it has certainly been a challenge to keep up with the ever-changing regulations (that’s likely to continue for a little longer), exciting new opportunities have also been created, such as the expansion of telemedicine. There’s also the maze of government funding that needs to be navigated and an increased awareness of OSHA standards to implement.
The CDC has released additional information and coding guidance for reporting encounters related to the 2019 health care encounters and deaths related to e-cigarette, or vaping, product use associated lung injury (EVALI).
The update offers coding scenarios for general guidance, poisoning and toxicity, substance abuse and signs and symptoms.
ICD-10-CM Official Coding Guidelines - ...
On April 30, 2020, CMS announced additional sweeping changes to meet the challenges of providing adequate healthcare during this pandemic. These changes expand the March 31st changes. The article covers some of the key changes. See the official announcement in the references below.
Risk adjustment is simply a way of making sure that there are sufficient funds to adequately take care of the healthcare needs of a certain population. It’s a predictive modeling methodology based on the diagnoses of the individuals in that population. As payers move to value based models, they heavily rely on risk adjustment to ensure proper funding.
All healthcare providers who are currently participating in the MIPS portion of Medicare’s Quality Payment Program may want to participate in the new COVID-19 Clinical Trials improvement activity. Read more about it here.
With all the new laboratory test codes that have been added due to the current public health emergency (PHE), there are a few additional guidelines CMS has released about collecting samples to perform the testing. Please keep in mind that these guidelines are by CMS and may or may not apply to other commercial payer policies.